Liraglutide Injection — FDA Drug Shortage

Current — Novo Nordisk, Inc.

The FDA lists a drug shortage record for Liraglutide Injection (injection) from Novo Nordisk, Inc. with status Current. The shortage was first posted on Jul 18, 2023. Reported reason: Delay in shipping of the drug

Shortage details

Status
Current
Company
Novo Nordisk, Inc.
Package NDC
0169-4060-13
Dosage Form
Injection
Presentation
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)
Initial Posting
Jul 18, 2023

Reason

Delay in shipping of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.